Review3 Biotech2023
Role of bio-electrochemical technology for enzyme activity stimulation in high-consumption pharmaceuticals biodegradation.
Review in 3 Biotech, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 10 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Active pharmaceutical ingredients (APIs) and their intermediate residues have recently been considered a serious concern. Among technologies, bio-electrochemical technologies (BETs) have stimulated the production of bio-electrical energy. This review aims to examine the benefit and mechanism of BETs on the degradation of high-consumption pharmaceutical compounds, including antibiotic, anti-inflammatory, and analgesic drugs, and the stimulation of enzymes induced in a bioreactor. Moreover, intermediates and the proposed pathways of pharmaceutical compound biodegradation in BETs are to be explained in this review. According to studies performed exclusively, the benefit of BETs is using bio-electroactive microbes to mineralize recalcitrant pharmaceutical contaminants by promoting enzyme activity and energy. Since BETs use the electron transfer chain between bio-anode/-cathode and pharmaceuticals, the enzyme activity is essential in the oxidation and reduction of phenolic rings of drugs and the ineffective detoxification of effluent from the treatment plant. This study is suggested a vital and influential role of BETs in mineralizing and enzyme induction in bioreactors. Eventually, a content of future developments or outlooks of BETs are propounded to improve the pharmaceutical industries' wastewater problems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.